HIPAA Compliance 360° Rotating Header Image

Posts Tagged ‘Carcinoma’

Does the hepatocellular phase of gadobenate dimeglumine help to differentiate hepatocellular carcinoma in cirrhotic patients according to histological grade?

Conclusion: Although the hepatocellular phase of gadobenate may help to differentiate some cases of WD HCC from the more aggressive grades, there is overlap between the different grades on qualitative and quantitative analysis. (Source: Clinical Radiology)
View full post on MedWorm: HIPAA

Detection of Recurrent Prostate Carcinoma with anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111In-Capromab Pendetide SPECT/CT [Nuclear Medicine]

Conclusion:
anti-3-18F-FACBC PET/CT was more sensitive than 111In–capromab pendetide SPECT/CT in the detection of recurrent prostate carcinoma and is highly accurate in the differentiation of prostatic from extraprostatic disease.
© RSNA, 2011
Supplemental material: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.11102023/-/DC1 (Source: Continuous Publishing articles)

MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other medical web [...]

Chemoembolization Follow-up of Hepatocellular Carcinoma with MR Imaging: Usefulness of Evaluating Enhancement Features on One-month Posttherapy MR Imaging for Predicting Residual Disease

Conclusions: This investigation shows high accuracy for using tumor enhancement features on 1-month posttherapy MR imaging to predict residual disease after chemoembolization of HCC. (Source: Journal of Vascular and Interventional Radiology : JVIR)
View full post on MedWorm: HIPAA

  • HIPAA Articles